title: [Methoxybutropate in the therapy of PID (pelvic inflammatory diseases)].
abstract: A study has been carried out on patients suffering from pelvic inflammatory disease (PID) in chronic form, so as to evaluate the effectiveness of treatment with methoxybutropate (Benflogin-Angelini). The study was carried out on 20 outpatients treated for eight weeks with 300 mg of methoxybutropate three times a day. The results have highlighted the noteworthy effectiveness and high tolerance of methoxybutropate in the treatment of PID.
authors.affiliation: Cattedra di Patologia, Ostetrica e Ginecologica, Università degli Studi, Milano.
authors.forename: A
authors.initials: A
authors.lastname: Stillo
authors.forename: A
authors.initials: A
authors.lastname: Rossi
authors.forename: M G
authors.initials: MG
authors.lastname: Lorenzin
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006139:Guaiacol / Q000031:analogs & derivatives; D006801:Humans; D007052:Ibuprofen / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; C020176:metoxibutropate; D006139:Guaiacol; D007052:Ibuprofen
vernacular_title: Il metossibutropato nella terapia delle PID.